1BP-LSD

1BP-LSD, also known as 1-(3- propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in December 2025. 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. 1BP-LSD is not an explicitly controlled substance in the United States or in Canada.

Classification

Chemical: Lysergamide
Psychoactive: Psychedelic

Effects

Dilated Pupils
Pupil Dilation
Stimulation
Nausea
Spontaneous Tactile Sensations
Introspection
Time Distortion
Conceptual Thinking
Novelty Enhancement
Analysis Enhancement
Visual Distortions
Color Enhancement
Drifting
Tracers
Pattern Recognition Enhancement

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu